These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

680 related articles for article (PubMed ID: 24749390)

  • 21. Oligo(lactic acid)n-Paclitaxel Prodrugs for Poly(ethylene glycol)-block-poly(lactic acid) Micelles: Loading, Release, and Backbiting Conversion for Anticancer Activity.
    Tam YT; Gao J; Kwon GS
    J Am Chem Soc; 2016 Jul; 138(28):8674-7. PubMed ID: 27374999
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Folate-conjugated amphiphilic hyperbranched block copolymers based on Boltorn H40, poly(L-lactide) and poly(ethylene glycol) for tumor-targeted drug delivery.
    Prabaharan M; Grailer JJ; Pilla S; Steeber DA; Gong S
    Biomaterials; 2009 Jun; 30(16):3009-19. PubMed ID: 19250665
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Preparation, characterization and Calu-3 cellular uptake of three kinds of poly(b-benzyl-L-amino)block-poly(ethylene glycol) nanoparticles].
    Zhou Y; Lu LN; Xin X; Huo DF; Wu HB; Qiu MF
    Yao Xue Xue Bao; 2013 Apr; 48(4):560-5. PubMed ID: 23833946
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Self-Assembled Monomethoxy (Polyethylene Glycol)-b-P(D,L-Lactic-co-Glycolic Acid)-b-P(L-Glutamic Acid) Hybrid-Core Nanoparticles for Intracellular pH-Triggered Release of Doxorubicin.
    Xu H; Cai C; Gou J; Sui B; Jin J; Xu H; Zhang Y; Wang L; Zhai Y; Tang X
    J Biomed Nanotechnol; 2015 Aug; 11(8):1354-69. PubMed ID: 26295138
    [TBL] [Abstract][Full Text] [Related]  

  • 25. cRGD conjugated mPEG-PLGA-PLL nanoparticles for SGC-7901 gastric cancer cells-targeted Delivery of fluorouracil.
    Liu P; Wang H; Wang Q; Sun Y; Shen M; Zhu M; Wan Z; Duan Y
    J Nanosci Nanotechnol; 2012 Jun; 12(6):4467-71. PubMed ID: 22905486
    [TBL] [Abstract][Full Text] [Related]  

  • 26. 5-Fluorouracil-loaded PLA/PLGA PEG-PPG-PEG polymeric nanoparticles: formulation, in vitro characterization and cell culture studies.
    Ocal H; Arica-Yegin B; Vural I; Goracinova K; Caliş S
    Drug Dev Ind Pharm; 2014 Apr; 40(4):560-7. PubMed ID: 23596973
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cell-Penetrating Peptide Modified PEG-PLA Micelles for Efficient PTX Delivery.
    Shuai Q; Cai Y; Zhao G; Sun X
    Int J Mol Sci; 2020 Mar; 21(5):. PubMed ID: 32182734
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bufalin-loaded mPEG-PLGA-PLL-cRGD nanoparticles: preparation, cellular uptake, tissue distribution, and anticancer activity.
    Yin P; Wang Y; Qiu Y; Hou L; Liu X; Qin J; Duan Y; Liu P; Qiu M; Li Q
    Int J Nanomedicine; 2012; 7():3961-9. PubMed ID: 22888239
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nanoparticles of poly(D,L-lactide)/methoxy poly(ethylene glycol)-poly(D,L-lactide) blends for controlled release of paclitaxel.
    Dong Y; Feng SS
    J Biomed Mater Res A; 2006 Jul; 78(1):12-9. PubMed ID: 16596586
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Preparation, characterization, and in vitro evaluation of docetaxel-loaded poly(lactic acid)-poly(ethylene glycol) nanoparticles for parenteral drug delivery.
    Liu D; Wang L; Liu Z; Zhang C; Zhang N
    J Biomed Nanotechnol; 2010 Dec; 6(6):675-82. PubMed ID: 21361132
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In vivo comparative study of distinct polymeric architectures bearing a combination of paclitaxel and doxorubicin at a synergistic ratio.
    Baabur-Cohen H; Vossen LI; Krüger HR; Eldar-Boock A; Yeini E; Landa-Rouben N; Tiram G; Wedepohl S; Markovsky E; Leor J; Calderón M; Satchi-Fainaro R
    J Control Release; 2017 Jul; 257():118-131. PubMed ID: 27374630
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A mPEG-PLGA-b-PLL copolymer carrier for adriamycin and siRNA delivery.
    Liu P; Yu H; Sun Y; Zhu M; Duan Y
    Biomaterials; 2012 Jun; 33(17):4403-12. PubMed ID: 22436800
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In vitro interaction of polyelectrolyte nanocapsules with model cells.
    Łukasiewicz S; Szczepanowicz K
    Langmuir; 2014 Feb; 30(4):1100-7. PubMed ID: 24410319
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Polyethylene glycol-poly(ε-benzyloxycarbonyl-l-lysine)-conjugated VEGF siRNA for antiangiogenic gene therapy in hepatocellular carcinoma.
    Wang G; Gao X; Gu G; Shao Z; Li M; Wang P; Yang J; Cai X; Li Y
    Int J Nanomedicine; 2017; 12():3591-3603. PubMed ID: 28533682
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A stable nanoplatform for antitumor activity using PEG-PLL-PLA triblock co-polyelectrolyte.
    Lim C; Sim T; Hoang NH; Oh KT
    Colloids Surf B Biointerfaces; 2017 May; 153():10-18. PubMed ID: 28192713
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lipid-polymer hybrid nanoparticles as a new generation therapeutic delivery platform: a review.
    Hadinoto K; Sundaresan A; Cheow WS
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):427-43. PubMed ID: 23872180
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of polyethylene glycol (PEG) chain organization on the physicochemical properties of poly(D, L-lactide) (PLA) based nanoparticles.
    Essa S; Rabanel JM; Hildgen P
    Eur J Pharm Biopharm; 2010 Jun; 75(2):96-106. PubMed ID: 20211727
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Preparation and characterization of poly(lactic acid)-poly(ethylene glycol)-poly(lactic acid) (PLA-PEG-PLA) microspheres for controlled release of paclitaxel.
    Ruan G; Feng SS
    Biomaterials; 2003 Dec; 24(27):5037-44. PubMed ID: 14559017
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Synthesis and evaluation of a paclitaxel-binding polymeric micelle for efficient breast cancer therapy.
    Xiang J; Wu B; Zhou Z; Hu S; Piao Y; Zhou Q; Wang G; Tang J; Liu X; Shen Y
    Sci China Life Sci; 2018 Apr; 61(4):436-447. PubMed ID: 29572777
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Paclitaxel loaded folic acid targeted nanoparticles of mixed lipid-shell and polymer-core: in vitro and in vivo evaluation.
    Zhao P; Wang H; Yu M; Liao Z; Wang X; Zhang F; Ji W; Wu B; Han J; Zhang H; Wang H; Chang J; Niu R
    Eur J Pharm Biopharm; 2012 Jun; 81(2):248-56. PubMed ID: 22446630
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 34.